Novel agents in CLL: the importance of affordability
Emili Montserrat, MD, PhD from the University of Barcelona, Barcelona, Spain discusses the issue of drug cost in chronic lymphocytic leukemia (CLL). Prof. Montserrat points out that not all patients ...
Author: VJHemOnc
Added: 07/27/2016
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts